# Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days

> **NCT01547169** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 60 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Placebo Comparator
- **DRUG:** insulin detemir
- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT01547169
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01547169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01547169, "Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01547169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*